2020
DOI: 10.1002/mnfr.202000015
|View full text |Cite
|
Sign up to set email alerts
|

Anti‐Inflammatory and Antioxidative Properties of Isoflavones Provide Renal Protective Effects Distinct from Those of Dietary Soy Proteins against Diabetic Nephropathy

Abstract: Scope: Dietary soy reportedly protects from diabetic nephropathy (DN), but its active components and mechanism of action remain unknown. Methods and results: In this study, KKAy mice are fed three types of diet: Dietary soy isoflavones with soy protein (Soy-IP) diet, reduced isoflavones soy protein (RisoP), and oral administration of isoflavones aglycones (IsoAgc). Albuminuria and glycosuria are decreased only in the soy-IP group. The risoP group show reduced expansion of mesangial matrix and renal fibrosis, t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(9 citation statements)
references
References 42 publications
(43 reference statements)
0
8
0
Order By: Relevance
“…In YBT-treated mice liver section, H&E staining displayed decreased adipocyte size and a smaller quantity of inflammatory cell infiltration ( Figure 3A bottom line). Then the H&E-stained liver sections were evaluated byNAS scoring system ( Choi et al, 2019 ). NAS of WD group was much higher than that of ND group.…”
Section: Resultsmentioning
confidence: 99%
“…In YBT-treated mice liver section, H&E staining displayed decreased adipocyte size and a smaller quantity of inflammatory cell infiltration ( Figure 3A bottom line). Then the H&E-stained liver sections were evaluated byNAS scoring system ( Choi et al, 2019 ). NAS of WD group was much higher than that of ND group.…”
Section: Resultsmentioning
confidence: 99%
“…Isoflavones protect the kidneys against diabetic nephropathy [125]. In a study using a mouse model for the condition, isoflavones were shown to reduce the expressions of Wnt4, β-catenin, and TGF-β1 that participate in the process of cell development, thereby decreasing urinary protein excretion and relieving renal histopathological damage.…”
Section: Improvement Of Renal Dysfunctionmentioning
confidence: 99%
“…PTK can be divided into non-receptor type and membrane receptor type according to whether PTK exists in the cell membrane receptor. The P160/steroid receptor coactivators (SRC-1, SRC-2, also known as NCOA1, NCOA2) family products represent the non-receptor type [24,25], which can regulate a variety of physiological reactions and clinical pathology. This pleiotropy is achieved through its inherent structural complexity, which enables this class of auxiliary regulators to control both nuclear and nonnuclear receptor signals, playing an important role in steroid hormone signaling [26].…”
Section: Discussionmentioning
confidence: 99%